SATIVEX

Search structure
Status: Approved
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Multiple Sclerosis; Muscle Spasticity; Sclerosis Phase 3 ClinicalTrials
Multiple Sclerosis; Sclerosis Phase 3 ClinicalTrials
Multiple Sclerosis; Sclerosis Phase 2 ClinicalTrials
Glioblastoma Phase 1/Phase 2 ClinicalTrials
Kidney Diseases; Kidney Failure, Chronic; Renal Insufficiency Phase 1 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Multiple Sclerosis; Muscle Spasticity; Sclerosis Phase 4 ClinicalTrials
Diabetic Neuropathies; Peripheral Nervous System Diseases Phase 3 ClinicalTrials
Multiple Sclerosis; Neuralgia; Sclerosis Phase 3 ClinicalTrials
Marijuana Abuse Phase 1 ClinicalTrials
Marijuana Abuse Phase 2 ClinicalTrials
Neuralgia Phase 3 ClinicalTrials
Hyperalgesia; Neuralgia; Peripheral Nervous System Diseases Phase 3 ClinicalTrials
Marijuana Abuse Phase 1 ClinicalTrials
Multiple Sclerosis; Muscle Spasticity; Sclerosis Phase 3 ClinicalTrials
Multiple Sclerosis; Neuralgia; Sclerosis Phase 3 ClinicalTrials
Cancer Pain Phase 3 ClinicalTrials
Glioblastoma Phase 1/Phase 2 ClinicalTrials
Cerebral Palsy; Muscle Spasticity Phase 3 ClinicalTrials
Mucositis; Squamous Cell Carcinoma of Head and Neck Phase 1 ClinicalTrials
CONTENTS